
Revealing the impact of tirzepatide treatment on muscle composition in type 2 diabetes
A recent analysis of the SURPASS-3 trial unravels the impact of treatment with the drug tirzepatide on muscle volume and fat infiltration in individuals with type 2 diabetes.This article was originally published on MedicalXpress.com